MedPath
HSA Approval

LAMISOPT EYE DROPS, SOLUTION 20 MG/ML

SIN14893P

LAMISOPT EYE DROPS, SOLUTION 20 MG/ML

LAMISOPT EYE DROPS, SOLUTION 20 MG/ML

November 5, 2015

LOTUS INTERNATIONAL PTE. LTD.

LOTUS INTERNATIONAL PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLOTUS INTERNATIONAL PTE. LTD.
Licence HolderLOTUS INTERNATIONAL PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

SOLUTION

OPHTHALMIC

Medical Information

S01EC03

dorzolamide

Manufacturer Information

LOTUS INTERNATIONAL PTE. LTD.

Rafarm S.A

Active Ingredients

DORZOLAMIDE HYDROCHLORIDE 22.260 mg/ml EQV DORZOLAMIDE

20.000 mg/ ml

Dorzolamide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.